IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SALVI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.217
NA - Nord America 3.777
AS - Asia 1.433
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 14
OC - Oceania 12
AF - Africa 11
Totale 9.481
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.738
PL - Polonia 1.382
DE - Germania 893
CN - Cina 791
UA - Ucraina 645
IT - Italia 410
FI - Finlandia 192
GB - Regno Unito 178
IN - India 169
HK - Hong Kong 167
FR - Francia 156
SG - Singapore 144
IE - Irlanda 105
RU - Federazione Russa 104
SE - Svezia 77
VN - Vietnam 75
BE - Belgio 43
CA - Canada 37
TR - Turchia 33
EU - Europa 17
IR - Iran 12
AU - Australia 11
BR - Brasile 10
KR - Corea 10
CZ - Repubblica Ceca 7
TH - Thailandia 7
MU - Mauritius 6
NL - Olanda 5
RO - Romania 5
BG - Bulgaria 3
KZ - Kazakistan 3
BD - Bangladesh 2
CL - Cile 2
GE - Georgia 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MY - Malesia 2
PK - Pakistan 2
SA - Arabia Saudita 2
SD - Sudan 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
IM - Isola di Man 1
JP - Giappone 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 9.481
Salva come PNG Salva come JPEG
Città #
Warsaw 1.382
Jacksonville 451
Fairfield 378
Chandler 361
Woodbridge 311
Ann Arbor 276
Ashburn 253
Houston 202
Princeton 196
Wilmington 181
Nanjing 167
Cambridge 163
Hong Kong 163
Beijing 155
Brescia 153
Seattle 133
New York 131
Helsinki 115
Dublin 105
Dearborn 87
Singapore 75
Dong Ket 70
Nanchang 53
Shenyang 49
Jinan 46
Changsha 45
Brussels 42
Hebei 42
Des Moines 41
Shanghai 40
Lancaster 36
Pune 34
Tianjin 34
Jiaxing 32
Milan 32
Los Angeles 29
Munich 28
Kocaeli 24
San Diego 24
Kunming 23
San Francisco 19
Nürnberg 18
Toronto 18
North York 17
Hangzhou 16
Ningbo 16
Verona 15
Boardman 13
Zhengzhou 11
Lappeenranta 9
Taizhou 9
Guangzhou 8
Haikou 8
Phoenix 8
Sundbyberg 8
Botucatu 7
Lanzhou 7
Magnago 7
Melbourne 7
Norwalk 7
Augusta 6
Bari 6
Brno 6
Fuzhou 6
Bologna 5
Borås 5
Castelnuovo Bozzente 5
London 5
Naples 5
Orange 5
Taiyuan 5
Brooklyn 4
Copertino 4
Hefei 4
Licata 4
Rockville 4
San Gregorio Magno 4
Suwon 4
Bhubaneswar 3
Daejeon 3
Hat Yai 3
Ho Chi Minh City 3
Indiana 3
Kilburn 3
Paris 3
Redwood City 3
Rosà 3
Sabz 3
San Paolo 3
Treviglio 3
Almaty 2
Altamura 2
Amsterdam 2
Ankara 2
Ardabil 2
Bursa 2
Casola in Lunigiana 2
Central 2
Changchun 2
Chongqing 2
Totale 6.533
Salva come PNG Salva come JPEG
Nome #
Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis 313
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 277
Cultured human amniocytes express hTERT, which is distributed between nucleus and cytoplasm and is secreted in extracellular vesicles 266
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 214
Analysis of a nanoparticle-enriched fraction of plasma reveals miRNA candidates for Down syndrome pathogenesis 199
Functional Role of microRNA-23b-3p in Cancer Biology 187
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 183
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 182
RET/PTC-1-driven transformation and pro-invasive phenotype of human thyrocytes depend on MET induction and alpha-catenin nuclear translocation 174
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 159
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 155
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 150
Long non-coding RNA GAS5 and miR-126-3p as molecular biomarkers of response to sorafenib in human cancer cells. 146
Biological Function of MicroRNA193a-3p in Health and Disease 137
Circulating ncRNAs as promising non-invasive molecular biomarkers of HCC 137
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 133
miR103 e miR-107 sono coinvolti nella regolazione dell'espressione di CDK5R1/p35 implicato nella migrazione neuronale. 131
Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC 131
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC 131
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 128
microRNAs and human hepatocellular carcinoma 123
Differential expression of miR-24 and miR27a in cirrhotic/non cirrhotic HCC. 122
The study of HCC cell specific miRNas reveals one novel human miR and miR-21, miR24 and miR-27a differential expression in HCC 119
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC. 116
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 112
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 110
The analysis of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24, and miR-27a differential expression in cirrhotic/non- cirrhotic HCC. 110
Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenib 110
Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells. 109
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 108
BRCA1 and BRCA2 genetic test in high risk patients and families : counselling and management 106
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 101
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 101
Sequential analysis of multistage hepatocarcinogenesis reveals that miR100 and PLK1 dysregulation is an early event maintained along tumor progression. 100
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 100
RT-PCR detection of telomerase in intraductal papillary mucinous tumours (IPMT) of the pancreas: preliminary findings. 99
Circulating microRNAs as promising non-invasive molecular biomarkers of HCC 99
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 98
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK-1 dysregulation is an early event maintained along tumor progression. 97
The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. 96
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells 96
Melatonin Effects on Non-Alcoholic Fatty Liver Disease Are Related to MicroRNA-34a-5p/Sirt1 Axis and Autophagy 96
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 95
Germline and somatic c-met mutations in multifocal/bilateral and sporadic papillary renal carcinomas of selected patients. 93
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 85
Does miR-338, a putative negative regulator of the facilitative glucose transporter 10 (GLUT10), play a role in arterial tortuosity syndrome? 83
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 81
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 79
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 76
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 73
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study 73
Urokinase and c-met are target of miR-23b in human cells. 72
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 71
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 69
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 69
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 67
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 66
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 66
FUNCTIONAL ROLE OF MICRORNA-23b-3p and MICRORNA-193a-3p IN CELL MIGRATION OF CANCER CELLS 65
Evidence on microRNAs mediated regulation of CDK5R1 gene expression. 64
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 63
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 63
The study of HCC-cell specific miRs reveals one novel human miR and miR-21, miR-24 and miR-27a differential expression in HCC 63
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 63
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 62
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 62
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 61
RNA interference for urokinase gene in human hepatocellular carcinoma 61
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 61
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 60
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 60
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 60
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 59
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 59
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 59
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 58
Determination of plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 58
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 57
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 57
Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings 56
Inherited duplication of the pseudoautosomal region Xq28 in a subject with Gilles de la Tourette syndrome and intellectual disability: A case report 56
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 55
Evidence on microRNAs mediated regulation of CDK5R1 gene expression 54
The FN13 peptide inhibits human tumor cells invasion through the modulation of alphavbeta3 integrins organization and the inactivation of ILK pathway 54
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 52
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 52
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 52
Plasmatic microRNA levels by ddPCR as peripheral biomarkers for IDH-wild type glioblastomas: a pilot study 51
Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells. 50
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 50
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 49
Identificazione e validazione di target terapeutici nel cancro mediante RNAi. Tecnologia RNA interference per tumori solidi. 47
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 46
MicroRNA‑34a‑5p expression in the plasma and its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study 46
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 46
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib 43
DNA methylation variations in familial female and male breast cancer 43
Emerging role of Telomeric-Repeat containing RNA TERRA in hepatocellular carcinoma 40
The enrichment of miR-23b-3p, miR-126-3p and GAS5 in extracellular vesicles from breast cancer cells treated with sorafenib inhibited the tumor growth of xenografts in zebrafish model 39
Identificazione di elementi in cis e di fattori in trans implicati nella regolazione post-trascrizionale del gene CDK5R1. 37
Totale 9.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.276 0 125 139 222 145 298 275 273 167 341 157 134
2020/20211.600 47 177 40 185 62 182 68 194 229 187 124 105
2021/2022847 48 155 47 47 7 30 25 52 48 91 94 203
2022/2023949 132 56 34 84 88 225 13 81 138 7 39 52
2023/20241.050 74 27 111 62 46 231 68 34 173 49 25 150
2024/202578 37 41 0 0 0 0 0 0 0 0 0 0
Totale 9.719